Business / Finance

RSS
Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction

Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction

TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies

TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies

Optibrium appoints Steve Yemm as Chief Commercial Officer

Optibrium appoints Steve Yemm as Chief Commercial Officer

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility

Andor Launches New ZL41 Cell and Sona sCMOS Cameras

Andor Launches New ZL41 Cell and Sona sCMOS Cameras

Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK

Porous PTFE components for demanding applications

Porous PTFE components for demanding applications

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse

H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support

H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support

Healthcare super fund HESTA directly invests in Inventia Life Science

Healthcare super fund HESTA directly invests in Inventia Life Science

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip